Alice mac Kain

Alice Mac Kain is a Senior Project Manager in Biomedical Discovery at Owkin, where project management and coordination focus on validating novel therapeutic targets in oncology. Previously, Alice served as a Postdoctoral Research Scientist at Institut Pasteur, researching nonreplicative recombination and SARS-CoV-2 immune response. Key accomplishments include the identification of DAXX as a restriction factor of SARS-CoV-2, presenting at international conferences, and publishing six articles. Alice also contributed to teaching at Université de Paris and participated in COVID TaskForce activities. Educational qualifications encompass a PhD in Microbiology, an MS in Infectiology, and a BS in Biology, all obtained from Université Paris Cité.